跳至主要内容
临床试验/CTRI/2024/07/071436
CTRI/2024/07/071436已完成不适用

Comparative study of effect of Karvellak Churna and Pathya Ahara in Pre Diabetes in relation to Meda Dhatu

Dr Shakuntala Nagar1 个研究点 分布在 1 个国家目标入组 90 人开始时间: 2024年10月21日最近更新:

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
90
试验地点
1
主要终点
Fasting blood sugar level 100 to 125 mg/dl

研究概览

简要总结

Diabetes mellitus is measure health problem in 21 century in year 2000 India is one of the five countries which have highest sufferers of diabetes mellitus, hence India is declared is capital of diabetes now in spite of advanced medical researches it is still burning issue that 50% of diabetic patient are remaining undiagnosed. Changing diet habits, lifestyle change, unbalanced diet, excess fast food, lacks of exercise are the reasons behind development of growth of diabetes and its root is in urbanization

Pre-diabetes is the precursor stage of Type-2 Diabetes Mellitus and often referred as ‘Grey area’ between diabetes and normal one. In recent years, the incidence of Prediabetes is rising with an alarming rate globally. It is also known as borderline diabetes, chemical diabetes & touch of diabetes. Obesity and insulin resistance are considered as it’s the main culprit and in due course of time it may lead to develop Type-2 Diabetes Mellitus.

Large percentage of population affected with DM-2. In this situation, by subsidizing or cure this disease at the pre-diabetes level through Ayurvedic medication & life style changes so patients can be saved from future diabetic complications. Main aim of this study to evaluate the clinical efficacy of Karvellaka Churna in pre-diabetic patients.

研究设计

研究类型
Interventional
分配方式
Na
盲法
None

入排标准

年龄范围
30.00 Year(s) 至 70.00 Year(s)(—)
性别
All

入选标准

  • Patients having clinical sign & symptoms of Prameha (prediabetes) according to Ayurveda and according to modern system of medicine.

排除标准

  • Patients with long term medication for diabetes and cytotoxic treatment.
  • Patients are suffering from serious illness of any of system.

结局指标

主要结局

Fasting blood sugar level 100 to 125 mg/dl

时间窗: 1month

Postprandial blood sugar level 140 to 199 mg/dl

时间窗: 1month

次要结局

  • Laboratory Investigation- Fasting blood sugar, Postprandial blood sugar, HbA1c test

研究者

发起方
Dr Shakuntala Nagar
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr Shakuntala Nagar

Goverment Ayurved college Kota

研究点 (1)

Loading locations...

相似试验